Simbol ABBV | |
Simbol | ABBV |
Simbol eToro | ABBV |
MarketWatch | ABBV |
Finviz | ABBV |
Yahoo Finance | ABBV |
Google Finance | ABBV |
TradingView | ABBV |
Investing.com | ABBV |
Wikipedia | AbbVie |
Denumire | AbbVie Inc. |
Website | abbvie.com |
Piața | NYSE |
ISIN | US00287Y1091 |
Sector | Health Technology |
Industrie | Pharmaceuticals Major |
Monedă | USD |
Preț | 161,6500 USD |
Capitalizare bursieră | 285,370 mld. USD |
P/E | 24,32 |
Beta | 0,4367 |
Dividend | 3,58% |
EPS | 6,6313 |
Profit anual | -4,82% |
Dată actualizare | 11.04.2023 |
Descriere |
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |
Data | P/E | Beta | Capitalizare | Dividend | EPS | Profit anual | Preț |
11.12.2021 | 29,89 | 0,7335 | 221,820 | 4,23% | 4,1983 | +20,20% | $125,47 |
05.12.2022 | 21,81 | 0,6055 | 289,430 | 3,49% | 7,5031 | +34,84% | $163,66 |
11.04.2023 | 24,32 | 0,4367 | 285,370 | 3,58% | 6,6313 | -4,82% | $161,65 |